A mosaic mutation of phosphate-regulating gene with homologies to endopeptidases on the X chromosome (PHEX) in X-linked hypophosphatemic rickets with mild bone phenotypes.
Asian People
/ genetics
Bone and Bones
/ abnormalities
Familial Hypophosphatemic Rickets
/ blood
Genetic Diseases, X-Linked
/ genetics
Humans
Japan
Male
Middle Aged
Mosaicism
PHEX Phosphate Regulating Neutral Endopeptidase
/ genetics
Parathyroid Hormone
/ blood
Phenotype
Phosphates
/ therapeutic use
Radiography
Sequence Deletion
/ genetics
Vitamin D
/ blood
Mosaicism
Phosphate-regulating gene with homologies to endopeptidases on the X chromosome
Rickets
X-linked hypophosphatemic rickets
Journal
Endocrine journal
ISSN: 1348-4540
Titre abrégé: Endocr J
Pays: Japan
ID NLM: 9313485
Informations de publication
Date de publication:
28 Sep 2021
28 Sep 2021
Historique:
pubmed:
29
4
2021
medline:
29
1
2022
entrez:
28
4
2021
Statut:
ppublish
Résumé
X-linked hypophosphatemic rickets (XLH) is primarily characterized by renal phosphate wasting with hypophosphatemia, short stature, and bone deformity of the leg. Here we present a male case of XLH with relatively mild bone deformity caused by a mosaic mutation of the phosphate-regulating gene with homologies to endopeptidases on the X chromosome (PHEX). Polymerase chain reaction (PCR) direct sequencing revealed a novel in-frame deletion, NM-000444.6:c.671-685del p.Gln224-Ser228del, at exon 6 in PHEX as a mosaic pattern. This mutation was not found in any database and may result in a significant change in higher-order protein structure and function. TA cloning of the PCR product and clone sequencing estimated the mutation allele frequency at 21%. Literature review of the previously reported three cases with novel mosaic mutations in PHEX, together with the present case, suggests that the rates of the mutation allele correlate with phenotype severity to some extent. We initially treated him with nutritional vitamin D supplements and phosphate salts. However, to avoid the development of secondary/tertiary hyperparathyroidism, we had switched nutritional to active vitamin D supplementation with reduced phosphorus salts. The present report contributes to understanding the relationship between the mosaic rate, in addition to the mutation locus, of the PHEX gene, and clinical features of XLH.
Identifiants
pubmed: 33907069
doi: 10.1507/endocrj.EJ20-0809
doi:
Substances chimiques
Parathyroid Hormone
0
Phosphates
0
Vitamin D
1406-16-2
PHEX Phosphate Regulating Neutral Endopeptidase
EC 3.4.24.-
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM